DE69802518T2 - Feste zusammensetzungen für orale verabreichung die l-carnitin- oder alkanoyl-l- carnitin-cholin-tartrat enthalten - Google Patents

Feste zusammensetzungen für orale verabreichung die l-carnitin- oder alkanoyl-l- carnitin-cholin-tartrat enthalten

Info

Publication number
DE69802518T2
DE69802518T2 DE69802518T DE69802518T DE69802518T2 DE 69802518 T2 DE69802518 T2 DE 69802518T2 DE 69802518 T DE69802518 T DE 69802518T DE 69802518 T DE69802518 T DE 69802518T DE 69802518 T2 DE69802518 T2 DE 69802518T2
Authority
DE
Germany
Prior art keywords
carnitine
alkanoyl
pct
solid compositions
oral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69802518T
Other languages
English (en)
Other versions
DE69802518D1 (de
Inventor
Mose Santaniello
Nazareno Scafetta
Maria Ornella Tinti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE69802518D1 publication Critical patent/DE69802518D1/de
Publication of DE69802518T2 publication Critical patent/DE69802518T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/40—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton with quaternised nitrogen atoms bound to carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Fodder In General (AREA)
DE69802518T 1997-04-18 1998-04-08 Feste zusammensetzungen für orale verabreichung die l-carnitin- oder alkanoyl-l- carnitin-cholin-tartrat enthalten Expired - Lifetime DE69802518T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000222A IT1291143B1 (it) 1997-04-18 1997-04-18 Composizioni solide atte alla somministrazione orale comprendenti l-carnitina colina tartrato o una alcanoil l-carnitina colina
PCT/IT1998/000080 WO1998047857A1 (en) 1997-04-18 1998-04-08 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine choline tartrate

Publications (2)

Publication Number Publication Date
DE69802518D1 DE69802518D1 (de) 2001-12-20
DE69802518T2 true DE69802518T2 (de) 2002-05-16

Family

ID=11404982

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69802518T Expired - Lifetime DE69802518T2 (de) 1997-04-18 1998-04-08 Feste zusammensetzungen für orale verabreichung die l-carnitin- oder alkanoyl-l- carnitin-cholin-tartrat enthalten

Country Status (17)

Country Link
US (1) US6080786A (de)
EP (1) EP0975581B1 (de)
JP (1) JP4046361B2 (de)
KR (1) KR100562052B1 (de)
AT (1) ATE208759T1 (de)
AU (1) AU731223B2 (de)
BR (1) BR9808908B1 (de)
CA (1) CA2286631C (de)
DE (1) DE69802518T2 (de)
DK (1) DK0975581T3 (de)
ES (1) ES2167889T3 (de)
HK (1) HK1025562A1 (de)
IT (1) IT1291143B1 (de)
NZ (1) NZ500535A (de)
PT (1) PT975581E (de)
SI (1) SI0975581T1 (de)
WO (1) WO1998047857A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306147B1 (it) 1999-05-28 2001-05-30 Biosalts Srl Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
IT1306186B1 (it) * 1999-09-03 2001-05-30 Biosalts Srl Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale
DE19956772A1 (de) * 1999-11-25 2001-06-07 Basf Ag Verwendung von y-Butyrobetain Salzen zur Herstellung von Zubereitungen für die menschliche und tierische Ernährung
DE20321010U1 (de) * 2003-03-28 2005-12-29 Schymura, Martin Fruchtgummizusammensetzung
BR102016009579A2 (pt) * 2016-04-28 2017-10-31 Geralatex Indl E Coml Prod Agro Florestais Nutritional food supplement formulated on the basis of pulp or humid watermelon factor, modified by hydration or reidrating, also known as tapioca, used as a source of carbohydrates and nucleus for formulations for food and dietary supplementation or, still as a partial substitute of meals for athletes or practicers of physical activities, its compositions and process

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1153640A (en) * 1967-04-10 1969-05-29 Soc D Etudes Prod Chimique A Carnitin Salt
FR2529545B1 (fr) * 1982-07-02 1985-05-31 Sanofi Sa Nouveaux sels de carnitine ainsi que leur procede de preparation
EP0150688B1 (de) * 1983-12-28 1987-04-22 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Salze von L-Carnitin und Alkanoyl-L-Carnitinen sowie Verfahren zur Herstellung derselben
US5001117A (en) * 1989-03-07 1991-03-19 Pharmacaps, Inc. Use of lecithin to restore olfaction and taste
CA2018137C (en) * 1989-06-14 2000-01-11 Thomas Scholl L-carnitine magnesium citrate
US5073376A (en) * 1989-12-22 1991-12-17 Lonza Ltd. Preparations containing l-carnitine
IT1261688B (it) * 1993-05-28 1996-05-29 Avantgarde Spa Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Also Published As

Publication number Publication date
US6080786A (en) 2000-06-27
ITRM970222A1 (it) 1998-10-18
WO1998047857A1 (en) 1998-10-29
CA2286631C (en) 2008-07-08
BR9808908B1 (pt) 2011-02-08
JP2002512613A (ja) 2002-04-23
DE69802518D1 (de) 2001-12-20
IT1291143B1 (it) 1998-12-29
AU7077798A (en) 1998-11-13
BR9808908A (pt) 2000-08-01
AU731223B2 (en) 2001-03-29
HK1025562A1 (en) 2000-11-17
KR100562052B1 (ko) 2006-03-17
ES2167889T3 (es) 2002-05-16
DK0975581T3 (da) 2002-03-25
SI0975581T1 (en) 2002-06-30
EP0975581B1 (de) 2001-11-14
NZ500535A (en) 2001-03-30
ATE208759T1 (de) 2001-11-15
CA2286631A1 (en) 1998-10-29
PT975581E (pt) 2002-04-29
KR20010006386A (ko) 2001-01-26
JP4046361B2 (ja) 2008-02-13
EP0975581A1 (de) 2000-02-02

Similar Documents

Publication Publication Date Title
DE69806590T2 (de) Feste zusammensetzungen für orale verabreichung die l-carnitine oder alkanoyl-l-carnitin-magnesium-fumarat enthalten
ATE230595T1 (de) Feste zusammensetzungen, die alkanoyl-l-carnitin- magnesium-zitrat enthalten, zur oralen verabreichung
ATE208758T1 (de) Feste zusammensetzungen für orale verabreichung die alkanoyl-l-carnitin-magnesium-tartrat enthalten
DE69802518T2 (de) Feste zusammensetzungen für orale verabreichung die l-carnitin- oder alkanoyl-l- carnitin-cholin-tartrat enthalten
DE69802789T2 (de) Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-carnitin-oder alkanoyl-l-carnitin mit 2-aminosulfonsäure enthalten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition